Why vaccines are a good investment

Why vaccines are a good investment An economist says lower health care costs are just the tip of the icebergBy Melinda Wenner David Bloom ARTICLE EXTRASThe Vaccine Conundrum David Bloom first became interested in international health in the late 1980s. At that time he was an established labor economist, and the economic aspects of the AIDS epid

Written byMelinda Wenner
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

An economist says lower health care costs are just the tip of the iceberg
By Melinda Wenner

David Bloom

ARTICLE EXTRAS

David Bloom first became interested in international health in the late 1980s. At that time he was an established labor economist, and the economic aspects of the AIDS epidemic intrigued him. Bloom recalls that his colleagues strongly discouraged him, telling him that "AIDS was a fad" and that "good scientists didn't work on trendy topics." He ignored them.

"Those kinds of comments had the unintended consequence of hastening my professional transition from US labor issues to global health," says Bloom, chair of the population and international health department at Harvard's School of Public Health. "And for the past 10 to 15 years, that's where I've concentrated my attention."

Bloom is perhaps best known for his 2005 study published in World Economics, with fellow Harvard economist David Canning and independent policy ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies